Skip to main content
SpringerLink
Log in

Prognosis and outcomes of lymphocyte-predominant Hodgkin's lymphoma

  • Practice Point
  • Published:

From Nature Clinical Practice Oncology

View current issue Sign up to alerts

An Erratum to this article was published on 01 August 2008

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wirth A et al. (2005) Long-term outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group. Cancer 104: 1221–1229

    Article  Google Scholar 

  2. Nogová L et al. (2005) Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG). Ann Oncol 16: 1683–1687

    Article  Google Scholar 

  3. Schulz H et al. (2008) Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG). Blood 111: 109–111

    Article  CAS  Google Scholar 

  4. Wedgwood AR et al. (2007) Rituximab + ABVD improves event-free survival (EFS) in patients with classical Hodgkin lymphoma in all international prognostic score (IPS) groups and in patients who have PET positive disease after 2–3 cycles of therapy [abstract]. Blood 110 (ASH Annual Meeting Abstracts): a215

    Google Scholar 

Download references

Acknowledgements

The synopsis was written by Mandy Aujla, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. G Suh is a Medical Oncology Fellow in the Division of Cancer Medicine, and A Younes is Professor of Medicine and Director of Clinical and Translational Research in the Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.,

    Grace Suh & Anas Younes

Authors
  1. Grace Suh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anas Younes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anas Younes.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suh, G., Younes, A. Prognosis and outcomes of lymphocyte-predominant Hodgkin's lymphoma. Nat Rev Clin Oncol 5, 368–369 (2008). https://doi.org/10.1038/ncponc1153

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc1153

  • Springer Nature Limited

This article is cited by

Search

Navigation